Zimmer Biomet Holdings, Inc. (ZBH) Stock Forecast
ZBH analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.54 / 5 from 28 analysts
- Price target
- $106.90 average of analyst targets
- Upside to target
- +12.6% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $1.89
- 52-week range
- $79.58 – $103.98
ZBH analyst ratings
28 analystsNumber of analysts at each rating.
ZBH price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ZBH earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.88 | $1.86 | $1.91 | $1.90 | −1.0% | 24 |
| Current fiscal year (2026) | $8.53 | $8.49 | $8.57 | $8.20 | +4.1% | 27 |
| Next fiscal year (2027) | $9.05 | $8.77 | $9.34 | $8.53 | +6.1% | 27 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ZBH revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.04B | $2.03B | $2.05B | +1.9% | 23 |
| Current fiscal year (2026) | $8.60B | $8.55B | $8.62B | +4.4% | 25 |
| Next fiscal year (2027) | $8.90B | $8.78B | $9.00B | +3.5% | 25 |
ZBH EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ZBH revenue: reported and forecast
ZBH EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.88 | $1.88 | $1.88 | $1.88 | $1.88 | +0.2% | 12 up · 7 down |
| Current fiscal year (2026) | $8.48 | $8.53 | $8.53 | $8.53 | $8.53 | +0.6% | 22 up · 1 down |
| Next fiscal year (2027) | $9.00 | $9.07 | $9.07 | $9.07 | $9.05 | +0.6% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ZBH earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ZBH beat in 12 of 12.
What analysts expect from ZBH
28 analysts cover Zimmer Biomet; their consensus rating is buy (3.54 on a 1–5 scale, where 5 is a strong buy). The average price target is $106.90, 12.6% above the latest close of $94.98. Analysts expect earnings of $8.53 per share for 2026, +4.1% from a year earlier. For 2027 the average estimate is $9.05 per share on revenue of $8.9 billion. Zimmer Biomet beat the EPS estimate in 12 of the last 12 quarters.
Related: ZBH income statement, ZBH key metrics, ZBH chart. See the ZBH stock overview for the latest quote and news.
ZBH forecast FAQ
What is Zimmer Biomet's price target?
The average analyst price target for Zimmer Biomet is $106.90, 12.6% above the latest close of $94.98.
Is Zimmer Biomet a buy, hold or sell?
Of 28 analysts covering Zimmer Biomet, 6 rate it a strong buy, 3 a buy, 19 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Zimmer Biomet's EPS forecast?
Analysts forecast $8.53 per share for 2026 (range $8.49 to $8.57); for 2027 the estimate is $9.05.
What is Zimmer Biomet's revenue forecast?
The average revenue estimate for 2026 is $8.6 billion, growth of 4.4%; for 2027 it is $8.9 billion.
When does Zimmer Biomet report earnings?
Zimmer Biomet is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens; the EPS estimate is $1.89.
Does Zimmer Biomet usually beat earnings estimates?
Zimmer Biomet reported EPS at or above the analyst estimate in 12 of the last 12 quarters.